EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

68Ga-FAPI PET/CT versus 18F-FDG PET/CT: Differentiating Metastatic Disease and Reactive Lymph Nodes in a Case of Carcinoma of Breast/Acquired Immunodeficiency Syndrome

Gopinathraj Gunasekaran iD, Jaykanth Amalachandran

World Journal of Nuclear Medicine · 01.09.2024 · 23 (03) · 217-219

DOI: 10.1055/s-0044-1787718 ↗

Kurz gefasst

Fallbericht in der Zeitschrift World Journal of Nuclear Medicine, erschienen am 01.09.2024. Verfasst von Gopinathraj Gunasekaran und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, PET-CT and Theranostics, Apollo Proton Cancer Centre, Chennai, Tamil Nadu, India. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gallium-68 (68Ga)-fibroblast activation protein inhibitor (FAPI) positron emission tomography (PET) images the cancer-associated fibroblast that forms a vital component of the tumor microenvironment. It is known that 68Ga-FAPI PET can aid in differentiating reactive lymph nodes from metastatic lymph nodes. 18F-fluorodeoxyglucose (FDG) PET/computed tomography (CT) is still the most commonly used PET radiopharmaceutical in the evaluation of a wide range of malignancies including breast carcinoma. Reactive lymph nodes may also show FDG uptake which can hinder optimal assessment for metastatic involvement. We report an interesting case of invasive ductal carcinoma of the right breast with associated World Health Organization clinical stage I acquired immunodeficiency syndrome for which 18F-FDG PET/CT and 68Ga-FAPI PET/CT were done.

Schlagwörter

Stichwörter der Autor:innen

68 Ga-FAPIPETacquired immunodeficiency syndromebreast carcinomametastatic nodepositron emission tomographyreactive node

Autor:innen und Institutionen

  • Department of Nuclear Medicine, PET-CT and Theranostics, Apollo Proton Cancer Centre, Chennai, Tamil Nadu, India.

ORCID-Profile: Gopinathraj Gunasekaran

Zitieren

APA

Gunasekaran, G., & Amalachandran, J. (2024). 68Ga-FAPI PET/CT versus 18F-FDG PET/CT: Differentiating Metastatic Disease and Reactive Lymph Nodes in a Case of Carcinoma of Breast/Acquired Immunodeficiency Syndrome. World Journal of Nuclear Medicine, 23(03), 217-219. https://doi.org/10.1055/s-0044-1787718

Vancouver

Gunasekaran G, Amalachandran J. 68Ga-FAPI PET/CT versus 18F-FDG PET/CT: Differentiating Metastatic Disease and Reactive Lymph Nodes in a Case of Carcinoma of Breast/Acquired Immunodeficiency Syndrome. World Journal of Nuclear Medicine. 2024;23(03):217-219. doi:10.1055/s-0044-1787718

BibTeX
@article{Gunasekaran2024,
  author = {Gunasekaran, Gopinathraj and Amalachandran, Jaykanth},
  title = {68Ga-FAPI PET/CT versus 18F-FDG PET/CT: Differentiating Metastatic Disease and Reactive Lymph Nodes in a Case of Carcinoma of Breast/Acquired Immunodeficiency Syndrome},
  journal = {World Journal of Nuclear Medicine},
  year = {2024},
  volume = {23},
  number = {03},
  pages = {217--219},
  doi = {10.1055/s-0044-1787718}
}
Kostenlos starten →